End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22,750 KRW | -0.44% | +1.56% | -15.74% |
2023 | Tranche Update on Korea United Pharm Inc.'s Equity Buyback Plan announced on July 15, 2022. | CI |
2023 | Tranche Update on Korea United Pharm Inc.'s Equity Buyback Plan announced on July 15, 2022. | CI |
Sales 2015 | 162B 118M | Sales 2016 * | 177B 129M | Capitalization | 335B 243M |
---|---|---|---|---|---|
Net income 2015 * | 19B 13.79M | Net income 2016 * | 18B 13.07M | EV / Sales 2015 | 1.65 x |
Net cash position 2015 * | 26.3B 19.09M | Net cash position 2016 * | 19.04B 13.82M | EV / Sales 2016 * | 1.78 x |
P/E ratio 2015 |
12.6
x | P/E ratio 2016 * |
20.4
x | Employees | 665 |
Yield 2015 |
1.26% | Yield 2016 * |
1.05% | Free-Float | 52.42% |
1 day | -0.44% | ||
1 week | +1.56% | ||
Current month | -3.60% | ||
1 month | -3.60% | ||
3 months | -10.78% | ||
6 months | -3.81% | ||
Current year | -15.74% |
Managers | Title | Age | Since |
---|---|---|---|
Won-Ho Kang
CEO | Chief Executive Officer | 47 | - |
Duk-Young Kang
CEO | Chief Executive Officer | 76 | - |
Won-Tae Jeong
BRD | Director/Board Member | 61 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Duk-Young Kang
CEO | Chief Executive Officer | 76 | - |
Gui-Ja Kim
BRD | Director/Board Member | 67 | - |
Won-Ho Kang
CEO | Chief Executive Officer | 47 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 22,750 | -0.44% | 39,859 |
24-04-23 | 22,850 | +0.22% | 14,229 |
24-04-22 | 22,800 | +1.33% | 27,405 |
24-04-19 | 22,500 | -1.10% | 17,072 |
24-04-18 | 22,750 | +1.56% | 19,993 |
End-of-day quote Korea S.E., April 23, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-15.74% | 243M | |
+19.69% | 42.78B | |
+18.72% | 22.25B | |
+13.12% | 14.39B | |
+11.67% | 13.55B | |
+35.11% | 11.27B | |
-9.58% | 6.95B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.29% | 5.01B |
- Stock Market
- Equities
- A033270 Stock